These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 1984890)

  • 1. Myocardial viability. What does it mean and how do we measure it?
    Gould KL
    Circulation; 1991 Jan; 83(1):333-5. PubMed ID: 1984890
    [No Abstract]   [Full Text] [Related]  

  • 2. Fluorine 18-labeled fluorodeoxyglucose myocardial single-photon emission computed tomography: an alternative for determining myocardial viability.
    Sandler MP; Patton JA
    J Nucl Cardiol; 1996; 3(4):342-9. PubMed ID: 8799254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concordance and discordance between stress-redistribution-reinjection and rest-redistribution thallium imaging for assessing viable myocardium. Comparison with metabolic activity by positron emission tomography.
    Dilsizian V; Perrone-Filardi P; Arrighi JA; Bacharach SL; Quyyumi AA; Freedman NM; Bonow RO
    Circulation; 1993 Sep; 88(3):941-52. PubMed ID: 8353921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of myocardial viability: where are we?
    McKillop JH
    Nucl Med Commun; 1994 Dec; 15(12):935-6. PubMed ID: 7715890
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO; Dilsizian V; Cuocolo A; Bacharach SL
    Circulation; 1991 Jan; 83(1):26-37. PubMed ID: 1984883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of thallium-201 single-photon emission tomography after rest injection and fluorodeoxyglucose positron emission tomography for assessment of myocardial viability in patients with chronic coronary artery disease.
    Altehoefer C; vom Dahl J; Buell U; Uebis R; Kleinhans E; Hanrath P
    Eur J Nucl Med; 1994 Jan; 21(1):37-45. PubMed ID: 8088284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved detection of viable myocardium with fluorodeoxyglucose-labeled single-photon emission computed tomography in a patient with hibernating myocardium: comparison with rest-redistribution thallium 201-labeled single-photon emission computed tomography.
    Bax JJ; Visser FC; Cornel JH; van Lingen A; Fioretti PM; Visser CA
    J Nucl Cardiol; 1997; 4(2 Pt 1):178-9. PubMed ID: 9115073
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of myocardial viability with positron emission tomography in a patient with ischemic cardiomyopathy.
    J Nucl Med; 1991 Jan; 32(1):130-5. PubMed ID: 1988617
    [No Abstract]   [Full Text] [Related]  

  • 9. Direct comparison of fluorine-18-FDG SPECT, fluorine-18-FDG PET and rest thallium-201 SPECT for detection of myocardial viability.
    Burt RW; Perkins OW; Oppenheim BE; Schauwecker DS; Stein L; Wellman HN; Witt RM
    J Nucl Med; 1995 Feb; 36(2):176-9. PubMed ID: 7830109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography detects metabolic viability in myocardium with persistent 24-hour single-photon emission computed tomography 201Tl defects.
    Brunken RC; Mody FV; Hawkins RA; Nienaber C; Phelps ME; Schelbert HR
    Circulation; 1992 Nov; 86(5):1357-69. PubMed ID: 1423947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Freedman NM; Perrone-Filardi P; Bacharach SL; Bonow RO
    Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability.
    Bax JJ; Visser FC; van Lingen A; Cornel JH; Fioretti PM; van der Wall EE
    Int J Card Imaging; 1997 Apr; 13(2):145-55; discussion 157-60. PubMed ID: 9110194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of myocardial uptake of fluorine-18-fluorodeoxyglucose imaged with PET and SPECT in dyssynergic myocardium.
    Bax JJ; Visser FC; Blanksma PK; Veening MA; Tan ES; Willemsen TM; van Lingen A; Teule GJ; Vaalburg W; Lie KI; Visser CA
    J Nucl Med; 1996 Oct; 37(10):1631-6. PubMed ID: 8862297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Functional/metabolic CAD diagnosis: arbutamine-RNV, stress-Echo, Tl-SPECT and gated FDG-PET].
    Adams S; Baum RP; Scholz M; Zeiher AM; Hör G
    Nuklearmedizin; 1997 Jun; 36(4):146-9. PubMed ID: 9289701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of myocardial ischemia using a rest metabolism/stress perfusion protocol with fluorine-18 deoxyglucose/technetium-99m MIBI and dual-isotope simultaneous-acquisition single-photon emission computed tomography.
    Sandler MP; Videlefsky S; Delbeke D; Patton JA; Meyerowitz C; Martin WH; Ohana I
    J Am Coll Cardiol; 1995 Oct; 26(4):870-8. PubMed ID: 7560611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activity in the areas of new fill-in after thallium-201 reinjection: comparison with positron emission tomography using fluorine-18-deoxyglucose.
    Tamaki N; Ohtani H; Yamashita K; Magata Y; Yonekura Y; Nohara R; Kambara H; Kawai C; Hirata K; Ban T
    J Nucl Med; 1991 Apr; 32(4):673-8. PubMed ID: 2013806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and economic controversies in radionuclide assessment of myocardial viability.
    Alagona P
    Circulation; 1995 Nov; 92(10):3145-6. PubMed ID: 7586290
    [No Abstract]   [Full Text] [Related]  

  • 18. Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.
    Tamaki N; Tadamura E; Kawamoto M; Magata Y; Yonekura Y; Fujibayashi Y; Nohara R; Sasayama S; Konishi J
    J Nucl Med; 1995 Nov; 36(11):1974-80. PubMed ID: 7472584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Potential and limitation of myocardial perfusion scintigraphy for detection of viability].
    Knapp WH
    Nuklearmedizin; 1995 Jun; 34(3):118-26. PubMed ID: 7630745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial F-18 fluorodeoxyglucose imaging by SPECT.
    Bax JJ; Visser FC; van Lingen A; Visser CA; Teule GJ
    Clin Nucl Med; 1995 Jun; 20(6):486-90. PubMed ID: 7648727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.